Quick Answer
CollPlant Biotechnologies Ltd reported Diluted EPS of $0.94 per share (loss) for fiscal year 2025.
CollPlant Biotechnologies Ltd Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.94 | +35.2% |
| 2024 | -$1.45 | -133.9% |
| 2023 | -$0.62 | +59.5% |
| 2022 | -$1.53 | -7750.0% |
| 2021 | $0.02 | +102.4% |
| 2020 | -$0.84 | +62.3% |
| 2019 | -$2.23 | — |
- CollPlant Biotechnologies Ltd showed an increase of +35.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, CollPlant Biotechnologies Ltd’s diluted eps has grown by 57.8% (from $2.23 per share (loss) to $0.94 per share (loss)).
- The most recent figure is from CollPlant Biotechnologies Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: